Who are we?
In the dynamic and constantly evolving environment of the pharmaceutical market within the Eurasian Economic Union (EAEU), Adelvas represents a new, yet exceptionally experienced, participant. Founded in 2023, our company is built upon a foundation of decades of practical experience held by its founders – recognized professionals in the EAEU pharmaceutical industry, whose cumulative tenure in senior management positions at leading global companies exceeds 20 years…
Sales and distribution in the EAEU market
We ensure efficient sales and distribution, guaranteeing timely access of patients to medicines in the territory of the EAEU, while observing quality standards and regulatory norms.
Commercial introduction of drugs into circulation
We have extensive experience and capabilities for the efficient and compliant commercial introduction of drugs into circulation in the EAEU.
Strategic Marketing and Brand Development
Our marketing strategy is aimed at creating brand value, effectively interacting with key healthcare stakeholders and stimulating demand in the EAEU.
Integrated Market Access Strategy
Ensuring market access is the cornerstone of our activities. We help make innovative medicines available to patients in the healthcare systems of the EAEU countries.
Pharmaceutical Logistics and Supply Chain Management
Our logistics expertise ensures safe, compliant and timely delivery of products throughout the EAEU.